Literature DB >> 22211008

Design of Allele Specific PCR for Rapid Detection of CYP3A5 (A6986G) and Mdr-1 (C3435T) Polymorphisms.

Tester F Ashavaid, Himanshu S Raje, Bharat V Shah, Swarup A Shah.   

Abstract

Single nucleotide polymorphisms in CYP3A5 (A6986G) and MDR-1 (C3435T) genes have been shown to be associated with the pharmacokinetics of tacrolimus in case of renal transplant recipients. Knowing these genotypes of the recipients before undergoing transplantation, is therefore essential for physicians to adjust the starting dose of tacrolimus in order to avoid drug induced nephrotoxicity. We have designed an allele specific PCR method for easier and rapid detection of these polymorphisms. 20 Indian renal transplant recipients on tacrolimus who developed nephrotoxicity within 1 month of transplantation and 58 Indian non-transplant subjects having the risk factors for kidney disease i.e. hypertension or diabetes or the family history of these, have been studied for these SNPs by allele specific PCR method. The data suggest that the heterozygosity of CYP3A5 and mutant allele frequency of MDR-1 SNP is higher in transplant patients as well as in general population.

Entities:  

Keywords:  Allele specific PCR; CYP3A5; MDR-1; Tacrolimus

Year:  2010        PMID: 22211008      PMCID: PMC3068768          DOI: 10.1007/s12291-010-0085-z

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  11 in total

Review 1.  Pharmacogenomics: translating functional genomics into rational therapeutics.

Authors:  W E Evans; M V Relling
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

2.  The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients.

Authors:  S H Akbas; T Bilgen; I Keser; M Tuncer; L Yucetin; O Tosun; M Gultekin; G Luleci
Journal:  Transplant Proc       Date:  2006-06       Impact factor: 1.066

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

Review 4.  Genetic contribution to variable human CYP3A-mediated metabolism.

Authors:  Jatinder K Lamba; Yvonne S Lin; Erin G Schuetz; Kenneth E Thummel
Journal:  Adv Drug Deliv Rev       Date:  2002-11-18       Impact factor: 15.470

5.  Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.

Authors:  Xin Zhang; Zhi-hong Liu; Jing-min Zheng; Zhao-hong Chen; Zheng Tang; Jin-song Chen; Lei-shi Li
Journal:  Clin Transplant       Date:  2005-10       Impact factor: 2.863

6.  Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus.

Authors:  Landry K Kamdem; Frank Streit; Ulrich M Zanger; Jürgen Brockmöller; Michael Oellerich; Victor W Armstrong; Leszek Wojnowski
Journal:  Clin Chem       Date:  2005-06-10       Impact factor: 8.327

7.  Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement.

Authors:  Iain A M Macphee; Salim Fredericks; Tracy Tai; Petros Syrris; Nicholas D Carter; Atholl Johnston; Lawrence Goldberg; David W Holt
Journal:  Transplantation       Date:  2002-12-15       Impact factor: 4.939

8.  Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms.

Authors:  HongXia Zheng; Steven Webber; Adriana Zeevi; Erin Schuetz; Jiong Zhang; Pamela Bowman; Gerard Boyle; Yuk Law; Susan Miller; Jatinder Lamba; Gilbert J Burckart
Journal:  Am J Transplant       Date:  2003-04       Impact factor: 8.086

Review 9.  Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics.

Authors:  Kazuhide Iwasaki
Journal:  Drug Metab Pharmacokinet       Date:  2007-10       Impact factor: 3.614

10.  Tacrolimus dosing in adult lung transplant patients is related to cytochrome P4503A5 gene polymorphism.

Authors:  HongXia Zheng; Adriana Zeevi; Erin Schuetz; Jatinder Lamba; Kenneth McCurry; Bartley P Griffith; Steven Webber; Julianne Ristich; James Dauber; Aldo Iacono; Wayne Grgurich; Diana Zaldonis; Kevin McDade; Jiong Zhang; Gilbert J Burckart
Journal:  J Clin Pharmacol       Date:  2004-02       Impact factor: 3.126

View more
  2 in total

1.  Investigation of CYP 3A5 and ABCB1 gene polymorphisms in the long-term following renal transplantation: Effects on tacrolimus exposure and kidney function.

Authors:  Nikola Z Stefanović; Tatjana P Cvetković; Tatjana M Jevtović-Stoimenov; Aleksandra M Ignjatović; Goran J Paunović; Radmila M Veličković
Journal:  Exp Ther Med       Date:  2015-06-26       Impact factor: 2.447

2.  Pharmacogenetics may Influence Tacrolimus Daily Dose, but not Urinary Tubular Damage Markers in the Long-Term Period after Renal Transplantation.

Authors:  Nikola Z Stefanović; Tatjana P Cvetković; Radmila M Veličković-Radovanović; Tatjana M Jevtović-Stoimenov; Predrag M Vlahović; Ivana R Stojanović; Dušica D Pavlović
Journal:  J Med Biochem       Date:  2015-09-19       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.